Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product Type (Synthesized Oligonucleotide Product, Reagents, Equipment), By Applications (Research, PCR, Sequencing, Gene Synthesis, Diagnostics, Therapeutics, RNAi, Nucleic Acid Aptamers, Others), By End-User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Anantika Sharma | Format:

Market Segmentation

  1. Oligonucleotide Synthesis Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Synthesized Oligonucleotide Product
    2. Reagents
    3. Equipment
  2. Oligonucleotide Synthesis Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Research
    2. PCR
    3. Sequencing
    4. Gene Synthesis
    5. Diagnostics
    6. Therapeutics
    7. RNAi
    8. Nucleic Acid Aptamers
    9. Others
  3. Oligonucleotide Synthesis Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Academic Research Institutes
    2. Pharmaceutical and Biotechnology Companies
    3. Diagnostic Laboratories
    4. Others
  4. Regional Oligonucleotide Synthesis Market
    1. North America
      1. North America Oligonucleotide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
      2. North America Oligonucleotide Synthesis Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Research
        2. PCR
        3. Sequencing
        4. Gene Synthesis
        5. Diagnostics
        6. Therapeutics
        7. RNAi
        8. Nucleic Acid Aptamers
        9. Others
      3. North America Oligonucleotide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Diagnostic Laboratories
        4. Others
      4. U.S.
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      5. Canada
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
    2. Europe
      1. Europe Oligonucleotide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
      2. Europe Oligonucleotide Synthesis Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Research
        2. PCR
        3. Sequencing
        4. Gene Synthesis
        5. Diagnostics
        6. Therapeutics
        7. RNAi
        8. Nucleic Acid Aptamers
        9. Others
      3. Europe Oligonucleotide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Diagnostic Laboratories
        4. Others
      4. U.K.
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      5. Germany
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      6. France
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      7. Spain
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      8. Italy
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      9. Russia
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      10. Nordic
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      11. Benelux
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      12. Rest of Europe
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
    3. APAC
      1. APAC Oligonucleotide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
      2. APAC Oligonucleotide Synthesis Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Research
        2. PCR
        3. Sequencing
        4. Gene Synthesis
        5. Diagnostics
        6. Therapeutics
        7. RNAi
        8. Nucleic Acid Aptamers
        9. Others
      3. APAC Oligonucleotide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Diagnostic Laboratories
        4. Others
      4. China
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      5. Korea
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      6. Japan
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      7. India
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      8. Australia
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      9. Singapore
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      10. Taiwan
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      11. South East Asia
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      12. Rest of Asia-Pacific
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
    4. Middle East and Africa
      1. Middle East and Africa Oligonucleotide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
      2. Middle East and Africa Oligonucleotide Synthesis Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Research
        2. PCR
        3. Sequencing
        4. Gene Synthesis
        5. Diagnostics
        6. Therapeutics
        7. RNAi
        8. Nucleic Acid Aptamers
        9. Others
      3. Middle East and Africa Oligonucleotide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Diagnostic Laboratories
        4. Others
      4. UAE
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      5. Turkey
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      6. Saudi Arabia
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      7. South Africa
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      8. Egypt
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      9. Nigeria
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      10. Rest of MEA
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
    5. LATAM
      1. LATAM Oligonucleotide Synthesis Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
      2. LATAM Oligonucleotide Synthesis Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Research
        2. PCR
        3. Sequencing
        4. Gene Synthesis
        5. Diagnostics
        6. Therapeutics
        7. RNAi
        8. Nucleic Acid Aptamers
        9. Others
      3. LATAM Oligonucleotide Synthesis Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Diagnostic Laboratories
        4. Others
      4. Brazil
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      5. Mexico
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      6. Argentina
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      7. Chile
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      8. Colombia
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others
      9. Rest of LATAM
        1. Synthesized Oligonucleotide Product
        2. Reagents
        3. Equipment
        4. Research
        5. PCR
        6. Sequencing
        7. Gene Synthesis
        8. Diagnostics
        9. Therapeutics
        10. RNAi
        11. Nucleic Acid Aptamers
        12. Others
        13. Academic Research Institutes
        14. Pharmaceutical and Biotechnology Companies
        15. Diagnostic Laboratories
        16. Others

We are featured on: